GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Spago Nanomedical AB (XSAT:SPAG BTA) » Definitions » Cyclically Adjusted Book per Share

Spago Nanomedical AB (XSAT:SPAG BTA) Cyclically Adjusted Book per Share : kr0.00 (As of Mar. 2025)


View and export this data going back to . Start your Free Trial

What is Spago Nanomedical AB Cyclically Adjusted Book per Share?

Note: As Cyclically Adjusted Book per Share is a main component used to calculate Cyclically Adjusted PB Ratio. If the month end stock price for this stock is zero, result may not be accurate due to the exchange rate between different shares and the data will not be stored into our database. Selected historical data showed in the calculation section below is only for demostration purpose.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Spago Nanomedical AB's adjusted book value per share for the three months ended in Mar. 2025 was kr7.093. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is kr0.00 for the trailing ten years ended in Mar. 2025.

During the past 12 months, Spago Nanomedical AB's average Cyclically Adjusted Book Growth Rate was -14.20% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was -6.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Spago Nanomedical AB was -6.40% per year. The lowest was -6.40% per year. And the median was -6.40% per year.

As of today (2025-07-23), Spago Nanomedical AB's current stock price is kr0.00. Spago Nanomedical AB's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 was kr0.00. Spago Nanomedical AB's Cyclically Adjusted PB Ratio of today is .

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Spago Nanomedical AB was 0.86. The lowest was 0.03. And the median was 0.06.


Spago Nanomedical AB Cyclically Adjusted Book per Share Historical Data

The historical data trend for Spago Nanomedical AB's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Spago Nanomedical AB Cyclically Adjusted Book per Share Chart

Spago Nanomedical AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Spago Nanomedical AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Spago Nanomedical AB's Cyclically Adjusted Book per Share

For the Biotechnology subindustry, Spago Nanomedical AB's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Spago Nanomedical AB's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Spago Nanomedical AB's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Spago Nanomedical AB's Cyclically Adjusted PB Ratio falls into.


;
;

Spago Nanomedical AB Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Spago Nanomedical AB's adjusted Book Value per Share data for the three months ended in Mar. 2025 was:

Adj_Book= Book Value per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=7.093/132.8245*132.8245
=7.093

Current CPI (Mar. 2025) = 132.8245.

Spago Nanomedical AB Quarterly Data

Book Value per Share CPI Adj_Book
201506 13.441 99.995 17.854
201509 13.057 100.228 17.303
201512 18.125 100.276 24.008
201603 17.501 100.751 23.072
201606 20.792 101.019 27.338
201609 20.424 101.138 26.823
201612 19.924 102.022 25.940
201703 19.368 102.022 25.216
201706 18.748 102.752 24.235
201709 18.044 103.279 23.206
201712 29.889 103.793 38.249
201803 31.615 103.962 40.392
201806 30.684 104.875 38.862
201809 34.816 105.679 43.759
201812 33.894 105.912 42.507
201903 42.375 105.886 53.156
201906 41.110 106.742 51.156
201909 39.697 107.214 49.180
201912 38.167 107.766 47.042
202003 36.575 106.563 45.589
202006 46.812 107.498 57.841
202009 45.563 107.635 56.226
202012 44.280 108.296 54.309
202103 60.418 108.360 74.059
202106 57.185 108.928 69.730
202109 54.383 110.338 65.466
202112 51.251 112.486 60.518
202203 48.511 114.825 56.115
202206 59.885 118.384 67.190
202209 57.769 122.296 62.742
202212 54.674 126.365 57.469
202303 50.696 127.042 53.004
202306 48.524 129.407 49.806
202309 46.480 130.224 47.408
202312 11.458 131.912 11.537
202403 9.505 132.205 9.550
202406 13.870 132.716 13.881
202409 11.403 132.304 11.448
202412 9.217 132.987 9.206
202503 7.093 132.825 7.093

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Spago Nanomedical AB  (XSAT:SPAG BTA) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Spago Nanomedical AB was 0.86. The lowest was 0.03. And the median was 0.06.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Spago Nanomedical AB Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Spago Nanomedical AB's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Spago Nanomedical AB Business Description

Industry
Traded in Other Exchanges
Address
Scheelevagen 22, Lund, SWE, SE-223 63
Spago Nanomedical AB is a nanomedicine company in the field of cancer diagnosis and treatment. The company's product includes SpagoPix and Tumorad. The SpagoPix product aims to improve cancer diagnosis with magnetic resonance imaging through the previous detection of tumors and metastases. The Tumorad products focus on the development of a completely new form of radionuclide therapy for tumor-selective radiation therapy of cancer. The company's development projects are based on a platform of polymeric materials with various properties for the precise diagnosis and treatment of life-threatening and debilitating diseases.

Spago Nanomedical AB Headlines

No Headlines